Yan Zhao

Yan Zhao

Auto-generated profile, based on publicly available information

Yan Zhao

National Laboratory of Biomacromolecules, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 April 2019 in Science
Verified
Journal Article
Closed access
PDF file
YZYan Zhao
Yan Zhao
SCShanshuang Chen
Shanshuang Chen
ASAdam C. Swensen
Adam C. Swensen
WQWei-Jun QIAN
Wei-Jun QIAN
EGEric Gouaux
Eric Gouaux
Diversity in ion channel complexes: AMPA receptors are glutamate activated ion channels that mediate fast synaptic transmission in the nervous system and play a key role in learning and memory. The receptors are tetramers built from various combinations of four subunits, with functional diversity coming from the range of subunit compositions. Zhao et al. purified native receptors from rat brains and determined the structures of 10 different complexes by cryo–electron microscopy. Certain arrangements of the four subunits are preferred. The structure of a key gating element—a linker between the transmembrane and ligand binding domains—reveals how this receptor may function. Science , this issue p. 355

9 June 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
YDYanli Dong
Yanli Dong
YGYiwei Gao
Yiwei Gao
AIAlina Ilie
Alina Ilie
DKDuSik Kim
DuSik Kim
ABAnnie Boucher
Annie Boucher
YZYan Zhao
Yan Zhao
Sodium/proton exchanger 1 (NHE1) is an electroneutral secondary active transporter present on the plasma membrane of most mammalian cells and plays critical roles in regulating intracellular pH and volume homeostasis. Calcineurin B-homologous protein 1 (CHP1) is an obligate binding partner that promotes NHE1 biosynthetic maturation, cell surface expression and pH-sensitivity. Dysfunctions of either protein are associated with neurological disorders. Here, we elucidate structures of the human NHE1-CHP1 complex in both inward- and inhibitor (cariporide)-bound outward-facing conformations. We find that NHE1 assembles as a symmetrical homodimer, with each subunit undergoing an elevator-like conformational change during cation exchange. The cryo-EM map reveals the binding site for the NHE1 inhibitor cariporide, illustrating how inhibitors block transport activity. The CHP1 molecule differentially associates with these two conformational states of each NHE1 monomer, and this association difference probably underlies the regulation of NHE1 pH-sensitivity by CHP1.

7 August 2024 in Nature
Verified
Journal Article
Closed access
PDF file
YLYue Li
Yue Li
XWXianping Wang
Xianping Wang
YMYufei Meng
Yufei Meng
THTuo Hu
Tuo Hu
JZJun Zhao
Jun Zhao
YZYan Zhao
Yan Zhao

11 March 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
XLXiaojing Li
Xiaojing Li
FXFeng Xu
Feng Xu
HXHao Xu
Hao Xu
SZShuli Zhang
Shuli Zhang
YGYiwei Gao
Yiwei Gao
DJDaohua Jiang
Daohua Jiang
Voltage-gated sodium (NaV) channels play fundamental roles in initiating and propagating action potentials. NaV1.3 is involved in numerous physiological processes including neuronal development, hormone secretion and pain perception. Here we report structures of human NaV1.3/β1/β2 in complex with clinically-used drug bulleyaconitine A and selective antagonist ICA121431. Bulleyaconitine A is located around domain I-II fenestration, providing the detailed view of the site-2 neurotoxin binding site. It partially blocks ion path and expands the pore-lining helices, elucidating how the bulleyaconitine A reduces peak amplitude but improves channel open probability. In contrast, ICA121431 preferentially binds to activated domain IV voltage-sensor, consequently strengthens the Ile-Phe-Met motif binding to its receptor site, stabilizes the channel in inactivated state, revealing an allosterically inhibitory mechanism of NaV channels. Our results provide structural details of distinct small-molecular modulators binding sites, elucidate molecular mechanisms of their action on NaV channels and pave a way for subtype-selective therapeutic development.

20 March 2024 in Cell
Verified
Journal Article
Closed access
YWYiqing Wei
Yiqing Wei
RLRenjie Li
Renjie Li
YMYufei Meng
Yufei Meng
THTuo Hu
Tuo Hu
JZJun Zhao
Jun Zhao
YZYan Zhao
Yan Zhao

1 November 2021 in Cell Reports
Verified
Journal Article
Open access
YDYanli Dong
Yanli Dong
YGYiwei Gao
Yiwei Gao
SXShuai Xu
Shuai Xu
YWYuhang Wang
Yuhang Wang
ZYZhuoya Yu
Zhuoya Yu
YZYan Zhao
Yan Zhao
N-type voltage-gated calcium (CaV) channels mediate Ca2+ influx at presynaptic terminals in response to action potentials and play vital roles in synaptogenesis, release of neurotransmitters, and nociceptive transmission. Here, we elucidate a cryo-electron microscopy (cryo-EM) structure of the human CaV2.2 complex in apo, ziconotide-bound, and two CaV2.2-specific pore blockers-bound states. The second voltage-sensing domain (VSD) is captured in a resting-state conformation, trapped by a phosphatidylinositol 4,5-bisphosphate (PIP2) molecule, which is distinct from the other three VSDs of CaV2.2, as well as activated VSDs observed in previous structures of CaV channels. This structure reveals the molecular basis for the unique inactivation process of CaV2.2 channels, in which the intracellular gate formed by S6 helices is closed and a W-helix from the domain II-III linker stabilizes closed-state inactivation. The structures of this inactivated, drug-bound complex lay a solid foundation for developing new state-dependent blockers for treatment of chronic pain.